|
1. How 8 health systems are avoiding a repeat of the 2023 chemo shortage Full story
2. The next GLP-1 bet? Implant draws Novo interest Full story
3. The 340B Rebate Reckoning is the most consequential policy shift pharmacy has faced in a decade, and the CPOs modeling its financial future are gathering Nov. 4-6 in Chicago. Apply to attend Becker’s Fall CPO Summit as a reviewer here.
4. Brand-name drug denials surge: JAMA Full story
5. CDC flips the script on where pharmacy deserts actually are: 5 notes Full story
6. 75% of hospitals now offer real-time medication pricing. Is yours getting it right? Find out here.
7. 6 GLP-1 findings to know Full story
8. GLP-1 drugmakers step in to promote Medicare’s Bridge program Full story
9. 2.5M+ prescription eye drop bottles recalled Full story
10. Hospital margins dip to 2.9% average as expenses grow, care shifts: 5 notes Full story
11. Why 720 rural hospitals are at risk of closing Full story
12. Unfilled prescriptions are quietly draining pharmacy and revenue cycle margins. See what’s recoverable here.
Becker’s Learning Opportunities
13. Ochsner, St. Luke’s, MetroHealth and Yale New Haven are moving pharmacy from cost control to growth driver. See how here.
14. GPO pricing discrepancies are costing pharmacies. See data-backed strategies to close the gap here.
15. Penn Medicine turned the patient room into a digital hub. See how here.
16. Becker’s resources don’t stop here — explore more webinars and whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
